Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,251,475
Closed -$4.58M 27
2025
Q2
$4.58M Buy
3,251,475
+1,194,838
+58% +$1.69M 3.81% 12
2025
Q1
$3.27M Buy
2,056,637
+981,813
+91% +$2.39M 2.95% 14
2024
Q4
$3.8M Sell
1,074,824
-256,229
-19% -$1.02M 3.26% 12
2024
Q3
$6.04M Sell
1,331,053
-1,405,610
-51% -$6.39M 3.23% 14
2024
Q2
$11.6M Sell
2,736,663
-23,834
-0.9% -$92.9K 6.91% 3
2024
Q1
$9.11M Sell
2,760,497
-211,142
-7% -$473K 5.06% 10
2023
Q4
$6.27M Buy
2,971,639
+750,000
+34% +$1.46M 3.74% 13
2023
Q3
$4.71M Buy
2,221,639
+98,477
+5% +$267K 5.53% 9
2023
Q2
$6.82M Buy
+2,123,162
New +$6.04M 8.25% 5

Other funds holding GERN

Ally Bridge Group's GERN Position: Q3 2025 in Review

Ally Bridge Group sold out of Geron (GERN) in Q3 2025, closing a stake of 3,251,475 shares — an estimated $4.58M sold.

Ally Bridge Group first reported a position in GERN in Q2 2023 and held it in 9 quarters. The position peaked at $11.6M in Q2 2024. 263 funds tracked by Wall St. Rank hold GERN as of Q3 2025.

  • Ally Bridge Group reported no remaining Geron position as of Q3 2025 after selling out during the quarter.
  • Ally Bridge Group sold 3,251,475 Geron shares in Q3 2025, an estimated $4.58M.
  • Ally Bridge Group first reported a position in Geron in Q2 2023 and held it in 9 quarters.
  • Ally Bridge Group's Geron position peaked at $11.6M in Q2 2024.
  • 263 funds tracked by Wall St. Rank held Geron as of Q3 2025.

Based on Ally Bridge Group's 13F filing for Q3 2025, filed 14 Nov 2025.